These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 324128)
21. [Antibodies to enteropathogenic bacteria in the saliva of patients with different forms of acute intestinal diseases and healthy subjects]. Gennad'eva TIa; Nikolaeva TA; Khazenson LB Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1976; 44():110-7. PubMed ID: 799368 [No Abstract] [Full Text] [Related]
22. Assessment of antibody screening in selection of subjects for field trials of Shigella vaccines. Cohen D; Green MS; Block C; Rouach T; Ofek I; Swartz T; Lowell G; Tramont E Ann Sclavo Collana Monogr; 1986; 3(1-2):151-4. PubMed ID: 3322338 [No Abstract] [Full Text] [Related]
23. Sonne dysentery in New Zealand. Markham NP; Shott HC N Z Med J; 1969 Jul; 70(446):15-20. PubMed ID: 4898234 [No Abstract] [Full Text] [Related]
24. [Comparative susceptibility of animals to Sonne and Flexner dysentery]. Suptel' IeO; Maksymovych NO; Borysov VA Mikrobiol Zh; 1976; 38(6):706-710. PubMed ID: 794642 [No Abstract] [Full Text] [Related]
25. [Intracellular parasitism of Shigella in patients with dysentery]. Kolesnikova AF; Vakulin GM Arkh Patol; 1975; 37(5):30-4. PubMed ID: 1106366 [TBL] [Abstract][Full Text] [Related]
26. [Nonspecific nature of antibody formation suppression by virulent Shigella sonnei]. Borisov VA; Frolov AF Mikrobiol Zh (1978); 1982; 44(1):71-6. PubMed ID: 7040918 [No Abstract] [Full Text] [Related]
27. [Comparative determination of lymphocyte functional activity and serum O-antibody titers in acute dysentery patients]. Bunin KV; Kosiakova NI Klin Med (Mosk); 1984 Feb; 62(2):50-3. PubMed ID: 6200646 [No Abstract] [Full Text] [Related]
28. [Use of immunofluorescence method in the diagnosis and study of pathogenesis of acute dysentery]. Pogorel'skaia LV; Vul'fovich IuV; Plotnikova IuK Sov Med; 1991; (6):84-6. PubMed ID: 1887317 [No Abstract] [Full Text] [Related]
29. [A comparative study of specific immunity in children at various periods of convalescence after acute Sonne dysentery]. Ankirskaia AS Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):27-30. PubMed ID: 4893973 [No Abstract] [Full Text] [Related]
30. [Biological peculiarities of the etiology in connection with various clinical manifestations of Sonne dysentery in children]. Omel'ianets' TH; Lukach IH; Bidenko AI Pediatr Akus Ginekol; 1975; (6):7-8. PubMed ID: 1105369 [No Abstract] [Full Text] [Related]
31. [Determination of the physicochemical nature of specific antibodies in the different forms and course of dysentery in children]. Nesterina LF; Vasil'eva IG Vopr Okhr Materin Det; 1973 Dec; 18(12):16-20. PubMed ID: 4594382 [No Abstract] [Full Text] [Related]
32. [Changes of various factors of nonspecific humoral immunity in acute dysentery]. Ebert LIa; Kolmogortseva VV Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):44-9. PubMed ID: 795232 [TBL] [Abstract][Full Text] [Related]
33. [The role of a secondary immunodeficiency in the pathogenesis of different forms of dysentery]. Usychenko EM; Mashilov VP Ter Arkh; 1991; 63(11):18-9. PubMed ID: 1810052 [No Abstract] [Full Text] [Related]
34. [The significance of the O antigen for the diagnosis of acute Sonne dysentery]. Ivanov KS; Poliakov SV; Sboĭchakov VB; Semenova IA; Sakal' NN Vrach Delo; 1990 May; (5):106-8. PubMed ID: 1697713 [TBL] [Abstract][Full Text] [Related]
35. Technological aspect of the production of live dysentery vaccines for oral administration. Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499 [TBL] [Abstract][Full Text] [Related]
36. [Comparative characteristics of the clinical course of Flexner and Sonne dysenteries during the warm and cold periods of the year]. Smetanin VN Klin Med (Mosk); 1979 Aug; 57(8):67-9. PubMed ID: 388064 [No Abstract] [Full Text] [Related]
37. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances. Munoz C; Baqar S; van de Verg L; Thupari J; Goldblum S; Olson JG; Taylor DN; Heresi GP; Murphy JR Am J Trop Med Hyg; 1995 Jul; 53(1):47-54. PubMed ID: 7542845 [TBL] [Abstract][Full Text] [Related]